References
- Fåhraeus L, Larsson-Cohn U, Wallentin L. Lipoproteins during oral and cutaneous administration of oestradiol-17β to menopausal women. Copenhagen: Acta Endocrinol 1982; 101: 592–6
- Fåhraeus L, Wallentin L. High density lipoprotein sub-fractions during oral and cutaneous administration of 17β-estradiol to menopausal women. J Clin Endocrinol Metab 1983; 56: 797–801
- Tikkanen M J., Kuusi T, Vartianen E, Nikkila E A. Treatment of postmenopausal hypercholesterolaemia with estradiol. Acta Obstet Gynecol Scand (Suppl) 1979; 88: 83–8
- Ross R K., Paganini-Hill A, Mack T M., Arthur M, Henderson B E. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet 1981; ii: 858–60
- Fåhraeus L, Larsson-Cohn U, Wallentin L. L-norgestrel and progesterone have different influences on plasma lipoproteins. Europ J Clin Invest 1983; 13: 447–53
- Hirvonen E, Mälkönen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Eng J Med 1981; 304: 560–3
- Larsson-Cohn U, Fåhraeus L, Wallentin L, Zador G. Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive. Fertil Steril 1981; 35: 172–9
- Thom M, Chakravarti S, Oram D H., Studd J WW. Effect of hormone replacement therapy on glucose tolerance in postmenopausal women. Br J Obstet Gynaecol 1977; 84: 776–84
- Boston collaborative drug surveillance program. Boston university medical center. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. N Engl J Med 1974; 290: 15–9
- Lindsay R, Hart D M., Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980; ii: 1151–4
- Lindsay R, Hart D M., MacLean A, Clark A C., Kraszewski A, Garwood J. Bone response to termination of oestrogen treatment. Lancet 1978; i: 1325–7
- Christiansen C, Christiansen M S., Transbol I B. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981; i: 459–61
- Horsman A, Gallagher J C., Simpson M, Nordin B EC. Prospective trial of oestrogen and calcium in postmenopausal women. Br Med J 1977; ii: 789–92
- Nordin B EC, Horsman A, Crilly R G., Marshall D H., Simpson M. Treatment of spinal osteoporosis in postmenopausal women. Br Med J 1982; i: 451–4
- Riggs B L., Seeman E, Hodgson S F., Taves D R., O'Fallon W M. Effect of fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. N Engl J Med 1982; 306: 446–50